Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-23-048824

Chief Financial Officer bought 10,000 shares at an average $1.99 ($19,853)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Byam Rebecca Chief Financial Officer 2023-09-07 Purchase +5,000 $1.95 $9,742 553,946 D
Byam Rebecca Chief Financial Officer 2023-09-08 Purchase +5,000 $2.02 $10,111 558,946 D
Open-market purchases · 10,000 sh · avg $1.99 · $19,853
Loading xslF345X05/doc4.xml…